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Research
AbstrACt
Objective To determine, using face-to-face diagnostic 
interviews, the prevalence of common mental disorders 
(CMD) in a cohort of adult Indigenous Australians, the 
cultural acceptability of the interviews, the rates of 
comorbid CMD and concordance with psychiatrists’ 
diagnoses.
Design Cross-sectional study July 2014–November 2016. 
Psychologists conducted Structured Clinical Interviews 
for Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition, Text Revision Axis I Disorders (SCID-I) 
(n=544). Psychiatrists interviewed a subsample (n=78).
setting Four Aboriginal Medical Services and the general 
community located in urban, regional and remote areas of 
Southern Queensland and two Aboriginal Reserves located 
in New South Wales.
Participants Indigenous Australian adults.
Outcome measures Cultural acceptability of SCID-I 
interviews, standardised rates of CMD, comorbid CMD and 
concordance with psychiatrist diagnoses.
results Participants reported that the SCID-I interviews 
were generally culturally acceptable. Standardised rates 
(95% CI) of current mood, anxiety, substance use and any 
mental disorder were 16.2% (12.2% to 20.2%), 29.2% 
(24.2% to 34.1%), 12.4% (8.8% to 16.1%) and 42.2% 
(38.8% to 47.7%), respectively—6.7-fold, 3.8-fold, 6.9-
fold and 4.2-fold higher, respectively, than those of the 
Australian population. Differences between this Indigenous 
cohort and the Australian population were less marked 
for 12-month (2.4-fold) and lifetime prevalence (1.3-fold). 
Comorbid mental disorder was threefold to fourfold higher. 
In subgroups living on traditional lands in Indigenous 
reserves and in remote areas, the rate was half that of 
those living in mainstream communities. Moderate-to-
good concordance with psychiatrist diagnoses was found.
Conclusions The prevalence of current CMD in this 
Indigenous population is substantially higher than 
previous estimates. The lower relative rates of non-current 
disorders are consistent with underdiagnosis of previous 
events. The lower rates among Reserve and remote area 
residents point to the importance of Indigenous peoples’ 
connection to their traditional lands and culture, and a 
potentially important protective factor. A larger study with 
random sampling is required to determine the population 
prevalence of CMD in Indigenous Australians.
IntrODuCtIOn
Australia’s Indigenous peoples, comprising at 
least 250 distinct language groups, have inhab-
ited the continent for 50 000–60 000 years 
and are likely the world’s oldest continuous 
culture outside Africa.1 At least 700 000 Indig-
enous people live in Australia, accounting 
for 3% of the overall Australian population.2 
Although estimates are confounded by inad-
equate or inconsistent data collection,3 little 
doubt exists that Indigenous Australians have 
marked health disparities compared with 
the general population—infant mortality is 
twofold, lifespan is at least 10 years shorter 
and death before age 65 years is three to four 
times more likely.4 Major disparities exist in 
all key social outcomes.5
As a result of over two centuries of Euro-
pean colonisation, Indigenous Australians 
have been exposed to multiple risk factors 
for poor mental health including dislocation 
strengths and limitations of this study
 ► This is the first study to use a face-to-face diag-
nostic interview capable of diagnosing all common 
mental disorders in an Indigenous Australian com-
munity cohort.
 ► The tool used was culturally acceptable to the partic-
ipants and showed moderate-to-good concordance 
with diagnoses made by psychiatrists experienced 
in Indigenous mental health.
 ► The geographical distribution of our cohort broadly 
matched that of the general Indigenous Australian 
population with the exception of remote and very 
remote residents.
 ► A significant limitation is that our sample was not 
randomly selected; however, cultural and other fac-
tors influence recruitment of Indigenous people for 
research so approaches differ from those used in 
mainstream research, and random sampling is high-
ly problematic.
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from homelands, kinship networks and family, leading to 
isolation.6 Loss of cultural and spiritual identity, self-es-
teem, security and happiness have led to a multitude of 
problems including family violence, welfare dependency, 
substance and alcohol misuse.7 Lack of understanding 
between Western and Indigenous concepts of mental 
disorder has contributed to deficiencies in policies that 
address these conditions. A burden of disease study 
done by the Australian Institute of Health and Welfare 
20118 reported that disability-adjusted life years (DALY) 
rates for Indigenous Australians were 2.3-fold higher 
than those for non-Indigenous Australians. Mental and 
substance use disorders were the leading cause of both 
total burden (19% of all DALY) and non-fatal burden 
(39% of all years living with disability (YLD)).
Despite mental health being estimated as a major 
contributor to the burden of disease, no robust data are 
available on the prevalence of common mental disor-
ders (CMD) among Indigenous Australians living in 
the community. This is because the majority of studies 
were in criminal justice and mental health settings, or 
restricted to very remote areas that may not be typical 
of the general Indigenous population.9 In very remote 
areas, Indigenous peoples comprise 50% of the total 
population, and they are more likely to speak an Indige-
nous language, identify with a clan/tribal group, live on 
or recognise traditional country, have contact with Elders 
and not be in the labour force.10 A study conducted in the 
remote Kimberly region of Western Australia sampled 
250 older Aboriginal adults (mean age 61 years, range 
46–89) from both isolated and urban populations.11 
Using a culturally sensitive tool (Kimberley Indigenous 
Cognitive Assessment of Depression) that was validated 
by psychiatrist’s assessments, the prevalence of current 
major depressive disorder was 4.3%, well above the rate 
of 1.7% in non-indigenous Australians aged 60 years or 
older.12
The only published representative study was the 
National Aboriginal and Torres Strait Islander Social 
Survey (NATSISS) conducted in 2014–2015 by the 
Australian Bureau of Statistics.10 This study, however, did 
not use a diagnostic interview but relied on participants 
reporting whether a doctor or nurse had told them that 
they had a mental health condition (depression, anxiety, 
substance use disorder, behavioural or emotional prob-
lems). According to NATSISS, 29% of Indigenous people 
over 15 years (33.7% of women and 24.6% of men) self-re-
ported that they have a mental health condition. Among 
those living in remote and very remote areas (22% of the 
total Indigenous population), the proportion reporting 
such a condition was half that of those living elsewhere 
(16.2% versus 33.1%). It is notable that Australia’s ‘bench-
mark’ mental health prevalence study, the 2007 National 
Survey of Mental Health and Wellbeing,13 included 8841 
from the general population but did not record their 
Indigenous status. The national prevalence study of chil-
dren’s mental health (Young Minds Matter)14 specifically 
excluded Indigenous children.
In this study, we used a structured psychiatric interview 
(Structured Clinical Interviews for Diagnostic and Statis-
tical Manual of Mental Disorders, Fourth Edition, Text 
Revision, Axis I Disorders (SCID-I)15 as opposed to self-re-
ported diagnoses, and a pragmatic recruitment approach, 
to estimate the standardised prevalence of CMD in a 
cohort of Indigenous Australians. Our additional objec-
tives were to determine the cultural acceptability of 
SCID-I, the rates of comorbid CMD and concordance 
between SCID-I and psychiatrist’s diagnoses.
MethODs
study design
We conducted a cross-sectional prevalence study between 
July 2014 and November 2016. The main outcome 
measure was the diagnosis of CMD as assessed by SCID-
I.15 Other outcome measures were the cultural accept-
ability of SCID-1 interviews, rates of comorbid CMD and 
concordance between SCID-1 and psychiatrist diagnoses.
Participants and recruitment
Participants were volunteers identifying as Aboriginal and/
or Torres Strait Islander, aged 18 years or older, living in 
Southern Queensland and an adjacent region in Northern 
New South Wales (NSW). Those with known cognitive 
impairment were excluded. Three subgroups were recruited 
from: (1) three Aboriginal Medical Services (AMS), 
comprising four sites located in metropolitan, regional and 
remote areas. AMS are health services funded by the Austra-
lian government principally to provide services to Indige-
nous people. Most are controlled by the local Indigenous 
community (Aboriginal Community Controlled Health 
Organisation), approximately 150 operate across Australia; 
(2) the general community and (3) two NSW Local Aborig-
inal Land Council (LALC) Reserves, where the majority of 
the population are Aboriginal people living on their tradi-
tional lands (‘on country’). These Reserves arose in 1983 
when the NSW government transferred freehold title for 
59 historical reserve and mission sites to 49 LALCs in whose 
area the land was situated, effectively providing Aboriginal 
collective ownership. The AMS sample was recruited first 
because of our strong engagement with Elders and commu-
nity. The three regional/rural AMS that contributed 84.7% 
of the AMS sample service three local government areas 
(LGA). They have 6100 registered Indigenous clients and 
are, therefore, reasonably likely to be representative of the 
7786 Indigenous people ≥15 years identified by the 2011 
Australian census as resident in these LGA. The total Indig-
enous population ≥15 years living in the surroundings of 
the metropolitan AMS is 4197 and the total Indigenous 
population ≥15 years of the two Reserves is 378. Thus, the 
total adult Indigenous population of the sampling frame 
can be estimated as approximately 12 000. Sixty-two per cent 
of Indigenous Australians live in Queensland and NSW.16 A 
map of Australia showing remoteness areas, study sites and 
approximate sampling area is shown in figure 1.
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Indigenous support workers recruited participants, 
assisted by posters in the waiting rooms. Recruitment 
of Reserve and community participants was by word of 
mouth and ‘snowballing’.17
Patient and public involvement
This research arose when local communities and Indige-
nous Elders expressed concern about the level of mental 
illness in their communities and our investigations found 
that robust evidence was lacking. Our proposal to conduct 
a prevalence study received overwhelming support from 
the communities. The involvement of 50 Indigenous 
participants in a pilot study (see the Cultural appropriate-
ness section) provided valuable feedback on the conduct 
of the study. Ongoing feedback from all participants was 
encouraged throughout the study. Participants informally 
assisted in recruiting via word of mouth and snowballing. 
On publication of this manuscript, the study results will be 
disseminated to participants and communities through 
AMS newsletters. It is expected that MRT will present the 
results to AMS boards and clients.
Diagnostic tool
SCID-I is conducted by a trained psychologist and uses 
both clinical judgement and information obtained 
through the tool to generate diagnoses. Current (30-day), 
12-month and lifetime diagnoses are assessed. SCID-I has 
been validated as a diagnostic tool with high inter-rater, 
multisite and test–retest reliability,18 although it has not 
been previously used in Indigenous Australians. Clin-
ical psychologists and Master of Psychology candidates 
(supervised by the former), trained in the use of the tool 
and in cultural awareness, conducted the assessments. 
Participants were provided the option of having an Indig-
enous Health Worker attend the interview. Weekly clin-
ical supervision by a senior academic clinical psychologist 
(GB) provided quality control. Psychologists completed 
diagnosis forms for each participant—a principal diag-
nosis and up to four other diagnoses were made.
Cultural appropriateness
A pilot study was conducted using SCID-I interviews on 
50 consenting Indigenous participants who were asked to 
Figure 1 Map of Australia showing remoteness areas, study sites and approximate sampling area. AMS, Aboriginal Medical 
Services. Rural denotes Inner Regional, Outer Regional, Remote or Very Remote. The map is based on Australian Bureau of 
Statistics data.19
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provide feedback on cultural issues. Based on qualitative 
data from the pilot, all participants of the present study 
were asked to complete a short anonymous open-ended 
questionnaire that explored cultural issues. Participants 
responded to questions that investigated how comfort-
able they felt during the interview, identifying questions 
that were uncomfortable for them, whether the inter-
viewer understood their responses and if there were 
any questions that should not be asked of Indigenous 
people. Survey responses were coded and content anal-
ysis performed.
Concordance
A random sample of participants was invited for a clinical 
interview with a consultant psychiatrist experienced in Indig-
enous mental health within 6 weeks of a SCID assessment. 
The psychiatrists did not have access to the SCID assessment 
at the time of the clinical interview. Concordance was deter-
mined using Cohen’s kappa coefficient (κ).
Data analysis and statistical methods
Crude prevalence rates of individual mental disorders and 
the major classes of disorders were stratified by age group, 
gender and recruitment location. The latter were cate-
gorised according to LGA and the Australian Standard 
Geographical Classification—Remoteness Area (ASGC-
RA)19 system. ASGC-RA 2–5 is considered rural. Stan-
dardised prevalence rates were calculated using the 2001 
Australian General Population standard and compared 
with data from the 2007 National Survey of Mental Health 
and Wellbeing(NSMHWB).13 The NSMHWB survey used 
WHO Composite International Diagnostic Interview 
(CIDI), which has high concordance with SCID-I.20 Data 
were entered in a secure Microsoft Access database and 
stored within university servers. Access was restricted to 
authorised staff members.
results
Participant characteristics
The characteristics of 544 Indigenous participants who 
completed SCID-I interviews are shown in table 1. As a 
significant majority (62%) were women, all crude data are 
presented by gender. The age distribution of the cohort 
is similar to that of Indigenous Australians nationwide.21
Cultural appropriateness results
Four hundred and ninety-eight participants self-completed 
post SCID-I questionnaires. The vast majority (95.6%) felt 
totally or mostly comfortable during the interview. Discom-
fort was related to questions about culture, personal matters, 
past life events, trauma, alcohol/substance use or because 
they did not know the psychologist. Eleven (2.2%) said 
that there were some inappropriate questions and a lack of 
cultural consideration.
Prevalence of mental disorders
The crude prevalence by diagnosis, diagnostic class, time-
frame and gender are shown in table 2. The most common 
diagnoses were post-traumatic stress disorder (PTSD), 
phobias and major depressive disorder. A small number 
of ‘other’ mental disorders present in 3.9% of the 
sample, including eating, psychotic/delusional, pain and 
body-dysmorphic disorders, are not included in the stan-
dardised data.
The prevalence of CMD standardised against the 
Australian general population ≥16 years by class and 
gender is shown in table 3. Rates of lifetime substance 
use disorders in men were almost double than those in 
women, while mood and anxiety disorders tended to be 
higher in women.
The absolute prevalence of all classes of disorders was 
higher than in the general Australian population6 particu-
larly for current diagnoses, where mood, anxiety, substance 
use or any mental disorder was 6.7-fold, 3.8-fold, 6.9-fold 
and 4.2-fold higher, respectively (table 3 and figure 2). 
Although the prevalence of 12-month and lifetime disor-
ders remained higher than the general population, the 
Table 1 Characteristics of study participants
Men
(n=207)
Women
(n=337)
Total
(n=544)
Age (mean (SD)) 41.8 (15.6) 41.9 (14.2) 41.9 (14.7)
Age group (n (%))
  18–24 35 (16.9) 40 (11.9) 75 (13.8)
  25–34 40 (19.3) 81 (24.0) 121 (22.2)
  35–44 45 (21.7) 72 (21.4) 117 (21.5)
  45–54 40 (19.3) 72 (21.4) 112 (20.6)
  55–64 25 (12.1) 46 (13.6) 71 (13.1)
  65+ 22 (10.6) 26 (7.7) 48 (8.8)
Indigenous status (n (%))
  Aboriginal 195 (94.2) 324 (96.1) 519 (95.4)
  Torres Strait Islander 5 (2.4) 3 (0.9) 8 (1.5)
  Aboriginal and Torres 
Strait Islander
7 (3.4) 10 (3.0) 17 (3.1)
Recruitment location (n (%))
  Aboriginal Medical 
Services
168 (81.2) 252 (74.8) 420 (77.2)
  Community 39 (18.8) 85 (25.2) 124 (22.8)
  Reserves 25 (12.1) 45 (13.4) 70 (12.9)
Regional distribution
  ASGC-RA 1: Major 
Cities
34 (16.4) 49 (14.5) 83 (15.3)
  ASGC-RA 2: Inner 
Regional
121 (58.5) 185 (54.9) 306 (56.3)
  ASGC-RA 3: Outer 
Regional
45 (21.7) 85 (25.2) 130 (23.9)
  ASGC-RA 4: Remote 6 (2.9) 16 (4.7) 22 (4.0)
  ASGC-RA 5: Very 
Remote
1 (0.5) 2 (0.6) 3 (0.6)
ASGC-RA, Australian Standard Geographical Classification—
Remoteness Areas.
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rate ratios were substantially less—2.2-fold to 3.4-fold for 
12-month and 1.3-fold to 2.2-fold for lifetime.
subgroup analyses
The rates of current CMD in the AMS and community 
subgroups were not significantly different. Substantially 
lower rates, however, were found in the Reserve subgroup, 
especially for mood and anxiety disorders. For example, 
the rates of current mood, anxiety and substance use 
disorders were approximately one-third, one-half and 
two-thirds, respectively, lower than those in the AMS 
subgroup (table 4). Nevertheless, they remained higher 
than those of the Australian general population—2.3-fold 
for mood disorder, 2.2-fold for anxiety disorder, 4.6-fold 
for substance use disorder and 2.5-fold higher for any 
CMD. After stratification by remoteness area (table 5), 
participants living in major cities, inner and outer regional 
(ASGC-RA 1–3) areas had similar rates of mental disor-
ders by class and duration. Those living in remote and 
very remote (ASGC-RA 4–5) (n=25), however, had signifi-
cantly lower rates of 30-day (approximately one-fifth), 
12-month (one-quarter) and lifetime (one-half) CMD.
Comorbid mental disorder
Comorbid mental disorder is defined as having diagnoses 
in two or more classes of CMD. The patterns of comorbid 
12-month CMD in women and men showed notable 
gender differences (figure 3). Among women, 17.5% 
had two and 4.2% had three classes of comorbid mental 
disorders; whereas among men, 10.1% had two and 3.9% 
had three comorbid mental disorders. As in women in 
the general population,22 comorbid mood and anxiety 
disorder was the most common combination at 20%. 
Comorbid mood and anxiety was present in 9.9% of the 
men. Among those with substance use disorders, 27.6% 
of men and 70.5% of women had another diagnosis. The 
rates of comorbid 12-month CMD in this Indigenous 
population were 4.0-fold higher in women and 3.0-fold 
higher in men, than reported in the general Australian 
population (NSMHWB).22 The Reserve subgroup had a 
much lower rate of comorbid mental disorder than the 
AMS subgroup—16.8% with any CMD have a diagnosis 
in more than one class compared with 31.0% in the AMS 
subgroup.
Table 2 Crude prevalence of common mental disorders
Thirty-day prevalence (n (%)) Twelve-month prevalence (n (%)) Lifetime prevalence (n (%))
Men
(n=207)
Women
(n=337)
Total
(n=544)
Men
(n=207)
Women
(n=337)
Total
(n=544)
Men
(n=207)
Women
(n=337)
Total
(n=544)
Mood disorders
  Major depressive 
disorder
19 (9.2) 37 (10.9) 56 (10.3) 24 (11.6) 47 (13.9) 71 (13.1) 38 (18.4) 92 (27.3) 130 (23.9)
  Dysthymic disorder 4 (1.9) 11 (3.73 15 (2.8) 4 (1.9) 11 (3.3) 15 (2.8) 5 (2.4) 12 (3.6) 17 (3.1)
  Bipolar disorders 1 (0.5) 8 (2.4) 9 (1.7) 1 (0.5) 8 (2.4) 9 (1.6) 2 (0.9) 11 (3.3) 13 (2.4)
  Any mood disorder 35 (16.9) 63 (18.7) 98 (18.0) 42 (20.3) 75 (22.3) 117 (21.5) 66 (31.9) 131 (38.9) 197 (36.2)
Anxiety disorders
  Panic disorder 7 (3.4) 25 (7.4) 32 (5.8) 13 (6.3) 33 (9.8) 46 (8.5) 15 (7.2) 51 (15.1) 66 (12.1)
  Social phobia 13 (6.3) 29 (8.6) 42 (7.7) 13 (6.3) 32 (9.5) 45 (8.3) 20 (9.7 41 (12.2) 61 (11.2)
  Specific phobia 17 (8.2) 37 (10.9) 54 (9.9) 17 (8.2) 38 (10.1) 55 (10.1) 20 (9.7) 46 (13.6) 66 (12.1)
  Generalised anxiety 
disorder
11 (5.3) 18 (5.3) 29 (5.3) 12 (5.8) 20 (5.9) 32 (5.9) 12 (5.7) 21 (6.2) 33 (6.1)
  Post-traumatic stress 
disorder
17 (8.2) 58 (17.2) 75 (13.8) 19 (9.2) 64 (18.9) 83 (15.3) 28 (13.5) 85 (25.2) 113 (20.8)
  Obsessive–
compulsive disorder
5 (2.4) 8 (2.74 13 (2.4) 5 (2.4) 9 (2.7) 14 (2.6) 5 (2.4) 11 (3.3) 16 (2.9)
  Any anxiety disorder 47 (22.7) 123 (36.5) 170 (31.3) 53 (25.6) 133 (39.5) 186 (34.2) 68 (32.9) 165 (49.0) 233 (42.8)
Substance use disorders
  Alcohol abuse 13 (6.3) 11 (3.73 24 (4.4) 24 (11.6) 16 (4.7) 40 (7.4) 53 (25.6) 52 (15.4) 105 (19.3)
  Alcohol dependence 21 (10.1) 15 (4.5) 36 (6.6) 32 (15.5) 23 (6.8) 54 (9.9) 59 (28.5) 66 (19.6) 125 (22.9)
  Substance abuse 6 (2.9) 5 (1.5) 11 (2.0) 11 (5.3) 7 (2.1) 18 (3.3) 33 (15.9) 14 (4.2) 47 (8.6)
  Substance 
dependence
9 (4.3) 8 (2.74 17 (3.1) 15 (7.3) 11 (3.3) 26 (4.8) 34 (16.4) 27 (8.0) 61 (11.2)
  Any substance use 
disorder
42 (20.3) 31 (9.2) 73 (13.4) 58 (28.0) 44 (13.1) 102 (18.8) 113 (54.6) 113 (33.5) 226 (41.5)
Any mental disorder* 99 (47.8) 148 (43.9) 247 (45.4) 116 (56.0) 165 (49.0) 281 (51.7) 151 (72.9) 213 (63.2) 364 (66.9)
*Any mental disorder within one or more of the three classes of anxiety, mood and substance use disorders.
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Concordance of sCID-I and psychiatrist diagnoses
Participants for the concordance study were sampled from 
all four AMS sites (sampling frame 420) but not from the 
community (participants scattered over a wide area) or 
Reserves (250–360 km travel for the two psychiatrists). The 
agreement (Cohen’s kappa) between SCID-I and psychia-
trist diagnoses among 78 participants who consented to 
both examinations was 0.55 for any mood disorder, 0.58 for 
any anxiety disorder, 0.67 for any substance use disorder and 
0.59 for any CMD. All values of κ are significant at p<0.001.
Psychiatrists tended to diagnose CMD slightly more often 
than SCID-I: current 43.6% versus 38.5%, 12-month 51.3% 
versus 42.3% and lifetime 76.9% versus 67.9%. The rate 
of current psychiatrist diagnoses was 4.4-fold than that of 
Table 3 Thirty-day, 12-month and lifetime prevalence of common mental disorders by diagnosis class and gender, 
standardised to and compared with the 2001 Australian general population (95% (CI))
Men
(n=207)
Women
(n=337)
Total Indigenous
(n=544)
Total NSMHWB*13
(n=8841)
Rate 
ratio†
30-day prevalence
  Any mood disorder 16.1 (12.1 to 20.1) 15.8 (11.8 to 19.8) 16.2 (12.2 to 20.2) 2.4 (1.9 to 2.8) 6.7
  Any anxiety disorder 22.0 (17.5 to 26.6) 32.4 (27.3 to 37.5) 29.2 (24.2 to 34.1) 7.7 (7.0 to 8.5) 3.8
  Any substance use disorder 19.4 (15.1 to 23.7) 7.8 (4.8 to 10.7) 12.4 (8.8 to 16.1) 1.8 (1.4 to 2.1) 6.9
  Any mental disorder‡ 45.8 (40.4 to 51.3) 38.7 (334 to 44.0) 42.2 (36.8 to 47.7) 10.0 (9.3 to 10.8) 4.2
12-month prevalence
  Any mood disorder 19.5 (15.2 to 23.8) 18.8 (14.5 to 23.1) 19.5 (15.1 to 23.8) 6.2 (5.5 to 6.9) 3.1
  Any anxiety disorder 24.9 (20.2 to 29.7) 34.9 (29.7 to 40.1) 31.9 (26.9 to 37.1) 14.4 (13.4 to 15.3) 2.2
  Any substance use disorder 26.3 (21.5 to 31.1) 11.0 (7.6 to 14.4) 17.1 (12.9 to 21.2) 5.1 (4.5 to 5.8) 3.4
  Any mental disorder‡ 53.6 (48.1 to 59.0) 42.9 (37.6 to 48.4) 47.9 (42.5 to 53.4) 20.0 (18.9 to 21.0) 2.4
Lifetime prevalence
  Any mood disorder 30.3 (25.2 to 35.3) 32.4 (27.2 to 37.5) 32.2 (27.1 to 37.3) 15.0 (14.1 to 16.0) 2.2
  Any anxiety disorder 31.0 (25.9 to 36.1) 42.4 (37.0 to 47.9) 38.9 (33.6 to 44.3) 26.3 (24.9 to 27.6) 1.5
  Any substance use disorder 49.9 (44.5 to 55.4) 28.7 (23.8 to 33.7) 37.2 (31.9 to 42.5) 24.7 (23.5 to 26.0) 1.5
  Any mental disorder‡ 68.2 (63.1 to 73.3) 54.4 (48.9 to 59.8) 60.6 (55.2 to 65.9) 45.5 (44.1 to 46.9) 1.3
*NSMHWB, National Survey of Mental Health and Wellbeing.13
†Rate ratio: total Indigenous % ÷ total NSMHWB %.
‡Any mental disorder within one or more of the three classes of anxiety, mood and substance use disorders.13
Figure 2 Standardised 30-day, 12-month and lifetime prevalence of common mental disorders among Indigenous Australians 
compared with the general Australian population. Superscripts are rate ratios; total Indigenous % ÷ total NSMHWB %. 
NSMHWB, National Survey of Mental Health and Wellbeing. 
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the general population but only 2.7-fold for 12-month and 
1.7-fold for lifetime, a pattern similar to the SCID-I results.
DIsCussIOn
Prevalence of CMD in Indigenous Australians
We found that the prevalence of any current CMD in this 
Indigenous cohort is markedly higher than in the general 
Australian population. Comorbid mental disorder was 
also much more common. The differences between the 
Indigenous and the general population, however, were 
substantially less for 12-month and lifetime disorders. It 
is implausible that this finding is due to a recent increase 
in incidence. Non-current diagnoses, whether by SCID-I 
or psychiatrist, depend on the person’s recall of previous 
Table 4 Standardised prevalence of common mental disorders by subgroup (95% (CI))
AMS
(n=420)
Community
(n=54)
Reserve
(n=70)
Total
(n=544)
30-day prevalence
  Any mood disorder 17.8 (13.6 to 22.0) 17.9 (13.7 to 22.1) 5.5 (3.0 to 8.0) 16.2 (12.2 to 20.2)
  Any anxiety disorder 31.7 (26.6 to 36.8) 27.9 (23.0 to 32.9) 17.0 (12.9 to 21.1) 29.2 (24.2 to 34.1)
  Any substance disorder 13.2 (9.5 to 16.9) 11.3 (7.8 to 14.8) 8.3 (5.3 to 11.3) 12.4 (8.8 to 16.0)
  Any mental disorder* 45.9 (40.4 to 51.3) 37.5 (32.2 to 42.8) 25.4 (20.7 to 30.2) 42.2 (36.8 to 47.6)
12-month prevalence
  Any mood disorder 21.5 (16.9 to 26.0) 20.3 (15.9 to 24.7) 6.8 (4.0 to 9.5) 19.5 (15.1 to 23.8)
  Any anxiety disorder 35.2 (29.9 to 40.4) 29.1 (24.2 to 34.1) 17.0 (12.9 to 21.1) 31.9 (26.9 to 37.1)
  Any substance disorder 17.5 (13.4 to 21.7) 15.2 (11.2 to 19.1) 16.4 (12.3 to 20.4) 17.0 (12.9 to 21.2)
  Any mental disorder* 52.3 (46.8 to 57.8) 38.7 (33.3 to 44.0) 30.7 (25.6 to 35.7) 47.9 (42.5 to 53.4)
Lifetime prevalence
  Any mood disorder 36.3 (31.0 to 41.6) 29.7 (24.7 to 34.7) 9.7 (6.5 to 12.9) 32.2 (27.1 to 37.3)
  Any anxiety disorder 42.8 (37.3 to 48.2) 31.7 (26.6 to 36.8) 23.8 (19.1 to 28.4) 38.9 (33.6 to 44.3)
  Any substance disorder 39.6 (34.2 to 44.9) 36.3 (31.0 to 41.6) 24.7 (19.9 to 29.4) 37.2 (31.9 to 42.5)
  Any mental disorder* 65.8 (60.6 to 71.0) 48.2 (42.7 to 53.7) 40.2 (34.8 to 45.6) 60.6 (55.2 to 65.9)
*Any mental disorder: any mental disorder from one or more of the three classes of anxiety, mood and substance use disorders.
AMS, Aboriginal Medical Services.
Table 5 Standardised prevalence of common mental disorders by remoteness (ASGC-RA) (95% (CI))
Major Cities
(n=83)
Inner Regional
(n=306)
Outer Regional
(n=130)
Remote/Very 
Remote (n=25)
30-day prevalence
  Any mood disorder 13.6 (9.9 to 17.7) 18.2 (13.9 to 22.4) 16.4 (12.3 to 20.4) 7.5 (4.6 to 10.3)
  Any anxiety disorder 24.7 (19.9 to 29.5) 36.4 (31.1 to 41.7) 22.4 (17.7 to 26.9) 5.3 (2.8 to 7.7)
  Any substance use disorder 19.2 (14.9 to 23.5) 10.0 (6.7 to 13.3) 14.5 (10.7 to 18.4) 2.2 (0.6 to 3.8)
  Any mental disorder* 42.8 (37.4 to 48.2) 47.8 (42.3 to 53.2) 36.9 (31.6 to 42.2) 7.5 (4.6 to 10.3)
12-month prevalence
  Any mood disorder 14.8 (10.9 to 18.7) 23.0 (18.4 to 27.7) 17.8 (13.6 to 22.0) 12.2 (8.6 to 15.7)
  Any anxiety disorder 27.5 (22.7 to 32.4) 39.4 (34.0 to 44.7) 25.6 (20.8 to 30.4) 5.3 (2.8 to 7.7)
  Any substance use disorder 22.8 (18.2 to 27.4) 14.5 (10.7 to 18.4) 20.0 (15.6 to 24.4) 9.9 (6.7 to 13.3)
  Any mental disorder* 48.5 (43.0 to 53.9) 53.3 (47.8 to 58.8) 44.3 (38.9 to 49.8) 12.2 (8.6 to 15.7)
Lifetime prevalence
  Any mood disorder 24.1 (19.4 to 28.7) 40.4 (35.0 to 45.8) 23.4 (18.7 to 28.0) 22.1 (17.6 to 26.7)
  Any anxiety disorder 31.8 (26.7 to 36.9) 47.4 (42.0 to 52.9) 31.9 (26.8 to 37.0) 21.8 (17.3 to 26.4)
  Any substance use disorder 39.2 (33.8 to 44.5) 39.1 (33.8 to 44.4) 36.4 (31.1 to 41.6) 17.1 (13.0 to 21.3)
  Any mental disorder* 56.2 (50.8 to 61.6) 68.5 (63.5 to 73.6) 54.2 (48.8 to 59.7) 27.1 (22.2 to 32.0)
*Any mental disorder within one or more of the three classes of anxiety, mood and substance use disorders.
ASGC-RA, Australian Standard Geographical Distribution—Remoteness Areas. 
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symptoms, episodes or being given a diagnosis by a 
health professional. Given that Indigenous people may 
not conceptualise a medical model of mental illness,23 
they may not recall such events. This attitude to illness 
is also likely to result in them not seeking medical advice 
regarding their symptoms. Furthermore, limited avail-
ability of mental health services, especially in rural areas, 
reduces opportunity to seek medical advice. If Indige-
nous patients do seek help, practitioners may be over-
whelmed by their multimorbid physical disorders, lack 
confidence in treating mental disorders and have limited 
options to refer to psychiatric services that are generally 
only accessible to those with severe mental disorders such 
as psychosis. The results of psychiatrist interviews also 
showed lower relative rates of 12-month and lifetime diag-
noses. Although the number of psychiatrist interviews was 
too low (n=78) to provide accurate prevalence data, this 
finding does suggest that the phenomenon is not just a 
characteristic of the SCID-I tool.
International comparisons
Limited data on rates of mental disorders are available 
in Indigenous communities worldwide. In a recent 
meta-analysis of 19 studies conducted in the Americas,24 
no differences were found in the 12-month prevalence 
of depressive, generalised anxiety and panic disorders 
between Indigenous and similar non-Indigenous groups. 
In five studies conducted in Canada, Brazil and the USA 
that compared rates of depressive disorders in Indige-
nous with non-Indigenous people, no differences were 
observed after adjusting for socioeconomic variables 
(overall OR 1.0). Indigenous people were, however, more 
likely to have 12-month PTSD and lifetime social phobia, 
both conditions characterised by fear. This is consistent 
with our finding that the most frequent 12-month stan-
dardised diagnoses were phobias and PTSD. A number 
of possibilities exist for the difference in our results with 
those of a meta-analysis from the Americas. One possibility 
is that some of the studies in the meta-analysis adjusted 
for more sociodemographic variables than age or sex 
as in the present study. These included socioeconomic 
status and educational level. This, however, is unlikely to 
be the sole explanation, as the lack of any overall differ-
ence for many of the outcomes was not greatly affected 
by adjustment for these variables. Another explanation 
might be that a sizeable proportion of the participants 
came from Reserves and, as in the present study, this may 
have some protective benefits. A third possibility is that 
there is a true difference between Indigenous peoples of 
the Americas and Australia such that even on Reserve, 
Indigenous Australians have higher rates of CMD. An 
alternative approach is to look at the relative contribution 
of mental health problems to the burden of disease faced 
by Indigenous populations.8 25
subgroup analyses
The AMS and community subgroups have similar high 
rates of current CMD, suggesting that recruiting through 
medical facilities has not caused significant bias. The 
rates of current CMD in the Reserve population are, 
however, 69% (mood), 46% (anxiety), 37% (substance 
use) and 45% (any) lower than those in the AMS popu-
lation despite there being similar major disparities in key 
social determinants.
Rates of CMD do not appear to be related to the popu-
lation size of the place of residence of participants, at least 
within the population range of 12 000 to 110 000. Those 
living in remote or very remote areas (at least 450–500 km 
Figure 3 Twelve-month crude prevalence of single and comorbid mood, anxiety and substance use disorders among 
Indigenous women and men.
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from a metropolitan area) appear, however, to have mark-
edly lower rates. This result should be interpreted with 
caution because of the small number, although it is consis-
tent with the results of the 2014–2015 NATSISS (approx-
imately 2500 remote Indigenous adults)10 and a study 
of 250 older Indigenous Kimberly residents.11 Impor-
tantly, many Indigenous Australians living in remote/
very remote areas live on traditional lands and in discrete 
majority-Indigenous communities. Our Reserve cohort 
resides in an area classified as Outer Regional although 
just 40 km from the Remote area boundary. Thus, it is not 
clear whether the lower rates of CMD is related to living 
in remote areas, in discrete communities, or on tradi-
tional land.
strengths and limitations
This is the first study to use a face-to-face diagnostic 
interview capable of diagnosing all CMD in an Indig-
enous Australian cohort. The tool used was culturally 
acceptable to the participants and showed moderate-
to-good concordance with diagnoses made by psychia-
trists experienced in Indigenous mental health.
Although the majority of participants were recruited 
in cities and towns, the distribution of their residential 
addresses matched the ASGC-RA distribution of the 
Indigenous Australian population with the exception of 
remote and very remote. It should be noted, however, 
that the NSMHWB13 did not include very remote areas so 
the prevalence of mental disorders in the general Austra-
lian population living in such areas is also unknown. 
Nevertheless, given the lower prevalence among remote/
very remote area residents, the fact that only 4.6% of our 
sample, compared with 21.4% of the overall Indigenous 
population, live in these areas is a significant weakness. 
Likewise, we have only sampled two Reserves.
Our prevalence rates have not been adjusted for socio-
economic variables, which are generally recognised to be 
associated with mental disorders.26 In Australia, however, 
data from the 2007 NSMHWB (n=6558)27 show that only 
those in the highest quintile of Index of Relative Social 
Disadvantage (IRSD) (ie, the most advantaged) had lower 
rates of CMD than those in the other four quintiles, with 
no evidence of ‘dose’ effect. Having any mental disorder 
was not associated with area of residence categorised as 
‘major urban’, ‘other urban’ or other. These data suggest 
that the very high rates of mental disorder in our cohort 
are unlikely to be related to their low IRSD or area of resi-
dence, although remote or very remote residence may be 
an exception.
A significant limitation is that our sample was not 
randomly selected. It is important to understand, 
however, that cultural and other factors influence 
recruitment of Indigenous people for research so 
approaches differ from those used in mainstream 
research, and random sampling is highly problem-
atic. Laycock et al28 have articulated the guiding prin-
ciples of research in Indigenous Australians spirit 
and integrity; reciprocity; respect; equality; survival 
and protection; and responsibility. The barriers and 
enablers of randomised sampling and recruitment in 
larger Indigenous epidemiological studies have been 
documented by Fox et al29 and Marin et al.30 A prereq-
uisite is meaningful and respectful engagement with 
Indigenous communities using community-specific 
approaches. Individuals in such communities volun-
teer to participate and do not appreciate the Western 
concept of being randomised ‘in’ or ‘out’ of the study, 
the latter being considered disrespectful. Some other 
barriers to randomised recruitment include the tran-
sient nature of Indigenous populations and house-
holds, the lack of robust site-specific population and 
household data,31 cultural requirements to attend 
funerals (‘sorry business’) and other community func-
tions, high-turnover of Indigenous staff, kinship struc-
tures within communities and high rates of substance 
abuse in some communities. In an example of a prag-
matic approach to recruitment, Brown and colleagues 
used non-random sampling of 436 Indigenous Austra-
lians living in remote, peri-urban (‘Town Camps’) and 
urban areas of the Northern Territory to conduct a 
cross-sectional prevalence study of the burden and 
determinants of cardiovascular and metabolic risk.32
the future
Indigenous Australians are culturally, geographically 
and sociologically diverse so a much larger study will 
be required to determine the total population prev-
alence of CMD, including further studies in Reserve 
and remote populations. Clearly, self-report surveys 
are inadequate: our findings highlight the impor-
tance of formal face-to-face diagnostic interviews 
using instruments such as SCID-I or CIDI33 rather 
than self-report surveys, in obtaining accurate esti-
mates of mental illness, although even with these, our 
results suggest that the diagnosis of past disorders is 
problematic in Indigenous populations.
In 2007, the Council of Australian Governments 
pledged to close key gaps in outcomes between Indige-
nous and non-Indigenous Australians. The Closing the 
Gap Program developed specific targets to reduce inequal-
ities in Indigenous life expectancy, mortality, education 
and employment but a decade later only three of seven of 
the current targets (those relating to child mortality, early 
childhood education and final year high school achieve-
ment) are on track to achieve targets.34 Recently, ‘Closing 
the Gap Refresh’ that aims to develop more appropriate 
and operational targets was launched.
Closing the Gap is an agreed Australian national 
priority35 and a strong case exists for Indigenous mental 
health to be a specific national priority. Thus, it is encour-
aging that Aboriginal and Torres Strait Islander Mental 
Health and Suicide Prevention is listed as a Priority Area 
in the Fifth National Mental Health Plan.36
Programmes addressing Indigenous mental health 
should incorporate the Indigenous concept of Social and 
Emotional Wellbeing, which recognises the importance of 
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connection to land, culture, spirituality, ancestry, family 
and community, and how these affect the individual.6 In 
addition, given the likely benefit of early diagnosis and 
treatment of mental disorders,37 routine screening may 
be warranted.
Our finding of much lower rates of CMD in Reserve 
and remote area residents suggests that the connection 
of Indigenous peoples to their traditional lands and their 
communities is an important determinant of their mental 
health. Thus, the possibility exists that facilitating the 
reconnection of Indigenous Australians to their lands 
may enhance their social and emotional wellbeing, and 
their mental health.38 39 Major barriers, however, to recon-
nection exist—historic events such as forced removal 
have broken the connections40 and native title has been 
‘extinguished’ by urbanisation and agricultural develop-
ment. It seems that under current Australian Native Title 
legislation, those most in need of reconnection with their 
lands are the least likely to achieve it.
Maintaining existing and building new connections 
to ‘country’ for Indigenous Australians is arguably best 
achieved by economic development within traditional 
lands/homelands by facilitating economic participation 
and leveraging land assets.34 For example, 43% of all land 
in the Northern Territory (ie, 0.6 million km2) is held 
under Native Title. Australian government programmes 
to build Indigenous economies such as the Indigenous 
procurement policy and the proposed Indigenous busi-
ness sector strategy hold promise.
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